An important question for mid-cap investors right now is how the ongoing uncertainty about the recovery in the broader economy will affect the share prices of companies like Advanced Medical Solutions. Advanced Medical Solutions shares...
|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for AMS
Some shares have withstood recent economic shockwaves better than others - but is Advanced Medical Solutions (LON:AMS) one of them? To understand why different shares respond to chaos in different ways, it pays to look at their strengt...
Shares in Advanced Medical Solutions (LON:AMS) are currently trading at 278p but a key question for investors is how heightened economic uncertainty will affect the price in the months to come. The answer comes down to judging whether...
The Advanced Medical Solutions (LON:AMS) share price is currently trading at 303.5p. But given the uncertain economic outlook, the question now is what the future holds for it. To try and predict where the Advanced Medical Solutions pr...
The Advanced Medical Solutions (LON:AMS) share price is currently trading at 292p. But given the uncertain economic outlook, the question now is what the future holds for it. To try and predict where the Advanced Medical Solutions pric...
Advanced Medical Solutions Group plc is primarily engaged in designing, developing, manufacturing and distributing wound care products, surgical dressings and medical grade materials, as well as medical adhesives and sutures for closing and sealing tissue. The Company operates through two business units for its sales, marketing and research and development (R&D) activities. Surgical business unit is focused on selling and marketing its branded products and are sold directly and through its distributors. Wound care business unit is focused on distribution and marketing its products that are supplied to medical device partners under its own brands. The Company’s products include ActivHeal, LiquiBand and RESORBA. Its technologies include collagen, cyanoacrylates, internal sealants, oxidized cellulose, sutures, alginates, foams, hydrocolloid and hydrogel.
Latest News for AMS
Upcoming Events for AMS
Half Year 2022 Advanced Medical Solutions Group PLC Earnings Release
As of Today at 07:00 UTC, shares in Advanced Medical Solutions are trading at 292.50p. This share price information is delayed by 15 minutes.
Shares in Advanced Medical Solutions last closed at 292.50p and the price had moved by -1.68% over the past 365 days. In terms of relative price strength the Advanced Medical Solutions share price has outperformed the FTSE All Share Index by +2.71% over the past year.
The overall consensus recommendation for Advanced Medical Solutions is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The Advanced Medical Solutions dividend yield is 0.67% based on the trailing twelve month period.
Last year, Advanced Medical Solutions paid a total dividend of £0.02, and it currently has a trailing dividend yield of 0.67%. We do not have any data on when Advanced Medical Solutions is to next pay dividends.
We do not have data on when Advanced Medical Solutions is to next pay dividends. The historic dividend yield on Advanced Medical Solutions shares is currently 0.67%.
To buy shares in Advanced Medical Solutions you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 292.50p, shares in Advanced Medical Solutions had a market capitalisation of £633.63m.
Here are the trading details for Advanced Medical Solutions:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: AMS
Based on an overall assessment of its quality, value and momentum Advanced Medical Solutions is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Advanced Medical Solutions is 307.00p. That is 4.96% above the last closing price of 292.50p.
Analysts covering Advanced Medical Solutions currently have a consensus Earnings Per Share (EPS) forecast of £0.10 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Advanced Medical Solutions. Over the past six months, its share price has underperformed the FTSE All Share Index by -1.22%.
As of the last closing price of 292.50p, shares in Advanced Medical Solutions were trading -3.36% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Advanced Medical Solutions PE ratio based on its reported earnings over the past 12 months is 27.38. The shares last closed at 292.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Advanced Medical Solutions' management team is headed by:
- Peter Allen - NEC
- Andrew Meredith - CEO
- Eddie Johnson - CFO
- Alan Richardson - COO
- Chris Locke - CTO
- Cathy Tomlinson - DHR
- Simon Coates - OTH
- Rose Guang - OTH
- Ross McDonald - OTH
- Pieter Van-Hoof - OTH
- Becky Walmsley - OTH
- Owen Bromley - SEC
- Grahame Cook - NID
- Penelope Freer - NID
- Douglas Le Fort - NID